Hereditary breast and ovarian cancer syndrome: The impact of race on uptake of genetic counseling and testing

Methods in Molecular Biology

Volumn 471, Issue , 2009, Pages 487-500

  Simon, Michael S ^a   Petrucelli, Nancie ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

BRCA1; BRCA2; Breast cancer; Primary care; Survival

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

AFRICAN AMERICAN; BREAST TUMOR; CAUCASIAN; ETHNOLOGY; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; GENETICS; HUMAN; MUTATION; OVARY TUMOR; PATIENT ATTITUDE; REVIEW; STATISTICS; SYNDROME; UNITED STATES;

AFRICAN AMERICANS; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; MUTATION; OVARIAN NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE; SYNDROME; UNITED STATES;

EID: 60349098715     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-416-2_25     Document Type: Review

References (65)

1. Merrill, R. M., Weed, D. L. (2001) Measuring the public health burden of cancer in the United States through lifetime and age-conditional risk estimates. Ann. Epidemiol. 11, 547-553.
2. Glanz, K., Croyle, R. T., Chollette, V. Y., Pinn, V. W. (2003) Cancer-related health disparities in women. Am. J. Public Health 93, 292-298.
3. Weir, H. K., Thun, M. J., Hankey, B. F., Ries, L. A., Howe, H. L., Wingo, P. A., Jemal, A., Ward, E., Anderson, R. N., Edwards, B. K. (2003) Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J. Natl. Cancer Inst. 95, 1276-1299.
4. Claus, E. B., Risch, N. J., Thompson, W. D. (1990) Age at onset as an indicator of familial risk of breast cancer. Am. J. Epidemiol. 131, 961-972.
5. Simon, M. S., Korczak, J. F., Yee, C. L., Malone, K. E., Ursin, G., Bernstein, L., McDonald, J. A., Deapen, D., Strom, B. L., Press, M. F., Marchbanks, P. A., Burkman, R. T., Weiss, L. K., Schwartz, A. G. (2006) Breast cancer risk estimates for relatives of white and African American women with breast cancer in the Women's Contraceptive and Reproductive Experiences Study. J. Clin. Oncol. 24, 2498-2504.
6. Du, W., Simon, M. S. (2005) Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit. Breast Cancer Res. Treat. 91, 243-248.
7. Simon, M. S., Banerjee, M., Crossley-May, H., Vigneau, D., Noone, A. M., Schwartz, K. (2005) Racial differences in breast cancer survival in the Detroit Metropolitan area. Breast Cancer Res Treat. 97, 149-55.
8. Newman, L. A, Griffith, K. A., Jatoi, I., Simon, M. S., Crowe, J. P., Colditz, G. A. (2006) Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J. Clin. Oncol. 24, 1342-1349.
9. Shavers, V. L., Brown, M. L. (2002) Racial and ethnic disparities in the receipt of cancer treatment. J. Natl. Cancer Inst. 94, 334-357.
10. O'Malley, C. D., Le, G. M., Glaser, S. L., Shema, S. J., West, D. W. (2003) Socioeconomic status and breast carcinoma survival in four racial/ethnic groups: a population-based study. Cancer 97, 1303-1311.
11. Ashton, C. M, Haidet, P., Paterniti, D. A., Collins, T. C., Gordon, H. S., O'Malley, K., Petersen, L. A., Sharf, B. F., Suarez-Almazor, M. E., Wray, N. P., Street, R. L Jr.,. (2003) Racial and ethnic disparities in the use of health services: bias, preferences, or poor communication? J. Gen. Intern. Med. 18, 146-152.
12. Joslyn, S. A. (2002) Racial differences in treatment and survival from early-stage breast carcinoma. Cancer 95, 1759-1766.
13. Shavers, V. L., Harlan, L. C., Stevens, J. L. (2003) Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer 97, 134-147.
14. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71.
15. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789-792.
16. Rebbeck, T. R., Lynch, H. T., Neuhausen, S. L., Narod, S. A., Van't Veer, L., Garber, J. E., Evans, G., Isaacs, C., Daly, M. B., Matloff, E., Olopade, O. I., Weber, B. L. (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N. Engl. J. Med. 346, 1616-1622.
17. Rebbeck, T. R, Friebel, T., Lynch, H. T., Neuhausen, S. L., van't Veer L, Garber, J. E., Evans, G. R., Narod, S. A., Isaacs, C., Matloff, E., Daly, M. B., Olopade, O. I., Weber, B. L. (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J. Clin. Oncol. 22, 1055-1062.
18. Ford, D., Easton, D. F., Bishop, D. T., Narod, S. A., Goldgar, D. E. (1994) Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343, 692-695.
19. Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., Sobol, H., Teare, M. D., Struewing, J., Arason, A., Scherneck, S., Peto, J., Rebbeck, T. R., Tonin, P., Neuhausen, S., Barkardottir, R., Eyfjord, J., Lynch, H., Ponder, B. A., Gayther, S. A., Zelada-Hedman, M. (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 62, 676-689.
20. Domchek, S. M., Friebel, T. M., Neuhausen, S. L., Wagner, T., Evans, G., Isaacs, C., Garber, J. E., Daly, M. B., Eeles, R., Matloff, E., Tomlinson, G. E., Van't, V. L., Lynch, H. T., Olopade, O. I., Weber, B. L., Rebbeck, T. R. (2006) Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncol. 7, 223-229.
21. Olopade, O. I., Fackenthal, J. D., Dunston, G., Tainsky, M. A., Collins, F., Whitfield-Broome, C. (2003) Breast cancer genetics in African Americans. Cancer 97, 236-245.
22. Ademuyiwa, F. O., Olopade, O. I. (2003) Racial differences in genetic factors associated with breast cancer. Cancer Metastasis Rev. 22, 47-53.
23. Nanda, R., Schumm, L. P., Cummings, S., Fackenthal, J. D., Sveen, L., Ademuyiwa, F., Cobleigh, M., Esserman, L., Lindor, N. M., Neuhausen, S. L., Olopade, O. I. (2005) Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. Jama 294, 1925-1933.
24. Armstrong, K., Micco, E., Carney, A., Stopfer, J., Putt, M. (2005) Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. Jama 293, 1729-1736.
25. Matthews, A. K., Cummings, S., Thompson, S., Wohl, V., List, M., Olopade, O. I. (2000) Genetic testing of African Americans for susceptibility to inherited cancers: use of focus groups to determine factors contributing to participation. J. Psychosoc. Oncol. 18, 1-19.
26. Kinney, A. Y., Croyle, R. T., Dudley, W. N., Bailey, C. A., Pelias, M. K., Neuhausen, S. L. (2001) Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: a survey of a large African-American kindred with a BRCA1 mutation. Prev. Med. 33, 543-551.
27. Couch, F. J., DeShano, M. L., Blackwood, M. A., Calzone, K., Stopfer, J., Campeau, L., Ganguly, A., Rebbeck, T., Weber, B. L. (1997) BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N. Engl. J. Med. 336, 1409-1415.
28. Phillips, K. A., Nichol, K., Ozcelik, H., Knight, J., Done, S. J., Goodwin, P. J., Andrulis, I. L. (1999) Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations. J. Natl. Cancer Inst. 91, 469-473.
29. Marcus, J. N., Watson, P., Page, D. L., Narod, S. A., Tonin, P., Lenoir, G. M., Serova, O., Lynch, H. T. (1997) BRCA2 hereditary breast cancer pathophenotype. Breast Cancer Res. Treat. 44, 275-277.
30. (1997) Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. Lancet 349, 1505-1510.
31. Verhoog, L. C., Brekelmans, C. T., Seynaeve, C., van den Bosch, L. M., Dahmen, G., van Geel, A. N., Tilanus-Linthorst, M. M., Bartels, C. C., Wagner, A., van den, O. A., Devilee, P., Meijers-Heijboer, E. J., Klijn, J. G. (1998) Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 351, 316-321.
32. Chen, V. W., Correa, P., Kurman, R. J., Wu, X. C., Eley, J. W., Austin, D., Muss, H., Hunter, C. P., Redmond, C., Sobhan, M.,. (1994) Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol.Biomarkers Prev. 3, 127-135.
33. Joslyn, S. A. (2002) Hormone receptors in breast cancer: racial differences in distribution and survival. Breast Cancer Res. Treat. 73, 45-59.
34. Simon, M. S., Severson, R. K. (1996) Racial differences in survival of female breast cancer in the Detroit metropolitan area. Cancer 77, 308-314.
35. Jones, B. A., Kasl, S. V., Howe, C. L., Lachman, M., Dubrow, R., Curnen, M. M., Soler-Vila, H., Beeghly, A., Duan, F., Owens, P. (2004) African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics. Cancer 101, 1293-1301.
36. Li, C. I., Malone, K. E., Daling, J. R. (2003) Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch. Intern. Med. 163, 49-56.
37. Grann, V., Troxel, A. B., Zojwalla, N., Hershman, D., Glied, S. A., Jacobson, J. S. (2005) Regional and racial disparities in breast cancer-specific mortality. Soc. Sci. Med.
38. Gao, Q., Neuhausen, S., Cummings, S., Luce, M., Olopade, O. I. (1997) Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer. Am. J. Hum. Genet. 60, 1233-1236.
39. Futreal, P. A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L. M., Haugen-Strano, A., Swensen, J., Miki, Y. (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266, 120-122.
40. Panguluri, R. C., Brody, L. C., Modali, R., Utley, K., Adams-Campbell, L., Day, A. A., Whitfield-Broome, C., Dunston, G. M. (1999) BRCA1 mutations in African Americans. Hum. Genet. 105, 28-31.
41. Stoppa-Lyonnet, D., Laurent-Puig, P., Essioux, L., Pages, S., Ithier, G., Ligot, L., Fourquet, A., Salmon, R. J., Clough, K. B., Pouillart, P., Bonaiti-Pellie, C., Thomas, G. (1997) BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group. Am. J. Hum. Genet. 60, 1021-1030.
42. Arena, J. F., Smith, S., Plewinska, M. (1996) BRCA1 mutations in African American women. Am. J. Hum. Genet. 59 (Suppl) A34.
43. Arena, J. F., Smith, S., Vincek, V. (1997) A BRCA1 founder mutation in African Americans. Am. J. Hum. Genet. 65 (Suppl) A325.
44. Mefford, H. C., Baumbach, L., Panguluri, R. C., Whitfield-Broome, C., Szabo, C., Smith, S., King, M. C., Dunston, G., Stoppa-Lyonnet, D., Arena, F. (1999) Evidence for a BRCA1 founder mutation in families of West African ancestry. Am. J. Hum. Genet. 65, 575-578.
45. Castilla, L. H., Couch, F. J., Erdos, M. R., Hoskins, K. F., Calzone, K., Garber, J. E., Boyd, J., Lubin, M. B., DeShano, M. L., Brody, L. C. (1994) Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat. Genet. 8, 387-391.
46. Shen, D., Wu, Y., Subbarao, M., Bhat, H., Chillar, R., Vadgama, J. V. (2000) Mutation analysis of BRCA1 gene in African-American patients with breast cancer. J. Natl. Med. Assoc. 92, 29-35.
47. Gao, Q., Adebamowo, C. A., Fackenthal, J., Das, S., Sveen, L., Falusi, A. G., Olopade, O. I. (2000) Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancer. Hum. Genet. 107, 192-194
48. Tambor, E. S., Bernhardt, B. A., Rodgers, J., Holtzman, N. A., Geller, G. (2002) Mapping the human genome: an assessment of media coverage and public reaction. Genet. Med. 4, 31-36.
49. Peters, N., Rose, A., Armstrong, K. (2004) The association between race and attitudes about predictive genetic testing. Cancer Epidemiol. Biomarkers Prev. 13, 361-365.
50. Donovan, K. A., Tucker, D. C. (2000) Knowledge about genetic risk for breast cancer and perceptions of genetic testing in a sociodemographically diverse sample. J. Behav. Med. 23, 15-36.
51. Armstrong, K., Weber, B., Ubel, P. A., Guerra, C., Schwartz, J. S. (2002) Interest in BRCA1/2 testing in a primary care population. Prev. Med. 34, 590-595.
52. Lipkus, I. M., Iden, D., Terrenoire, J., Feaganes, J. R. (1999) Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer. Cancer Epidemiol. Biomarkers Prev. 8, 533-539.
53. Hughes, C., Gomez-Caminero, A., Benkendorf, J., Kerner, J., Isaacs, C., Barter, J., Lerman, C. (1997) Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ. Couns. 32, 51-62.
54. Durfy, S. J., Bowen, D. J., McTiernan, A., Sporleder, J., Burke, W. (1999) Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiol. Biomarkers Prev. 8, 369-375.
55. Tambor, E. S., Rimer, B. K., Strigo, T. S. (1997) Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population. Am. J. Med. Genet. 68, 43-49.
56. Furr, L. A. (2002) Perceptions of genetics research as harmful to society: differences among samples of African-Americans and European-Americans. Genet. Test. 6, 25-30.
57. Bates, B. R., Lynch, J. A., Bevan, J. L., Condit, C. M. (2005) Warranted concerns, warranted outlooks: a focus group study of public understandings of genetic research. Soc. Sci. Med. 60, 331-344.
58. Sankar, P., Cho, M. K., Condit, C. M., Hunt, L. M., Koenig, B., Marshall, P., Lee, S. S., Spicer, P. (2004) Genetic research and health disparities. Jama 291, 2985-2989.
59. Hughes, C., Lerman, C., Lustbader, E. (1996) Ethnic differences in risk perception among women at increased risk for breast cancer. Breast Cancer Res Treat. 40, 25-35.
60. Durfy, S. J., Bowen, D. J., McTiernan, A., Sporleder, J., Burke, W. (1999) Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiol. Biomarkers Prev. 8, 369-375.
61. Brandon, D. T., Isaac, L. A., LaVeist, T. A. (2005) The legacy of Tuskegee and trust in medical care: is Tuskegee responsible for race differences in mistrust of medical care? J. Natl. Med. Assoc. 97, 951-956.
62. Thompson, H. S., Valdimarsdottir, H. B., Duteau-Buck, C., Guevarra, J., Bovbjerg, D. H., Richmond-Avellaneda, C., Amarel, D., Godfrey, D., Brown, K., Offit, K. (2002) Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women. Cancer Epidemiol. Biomarkers Prev. 11, 1579-1585.
63. Freedman, A. N., Wideroff, L., Olson, L., Davis, W., Klabunde, C., Srinath, K. P., Reeve, B. B., Croyle, R. T., Ballard-Barbash, R. (2003) US physicians' attitudes toward genetic testing for cancer susceptibility. Am. J. Med. Genet. 120, 63-71.
64. Lee, R., Beattie, M., Crawford, B., Mak, J., Stewart, N., Komaromy, M., Esserman, L., Shaw, L., McLennan, J., Strachowski, L., Luce, J., Ziegler, J. (2005) Recruitment, genetic counseling, and BRCA testing for underserved women at a public hospital. Genet. Test. 9, 306-312.
65. Schwartz, M. D., Hughes, C., Roth, J., Main, D., Peshkin, B. N., Isaacs, C., Kavanagh, C., Lerman, C. (2000) Spiritual faith and genetic testing decisions among high-risk breast cancer probands. Cancer Epidemiol. Biomarkers Prev. 9, 381-385.